People Briefs: EnteroMedics, Direct Flow Medical, Veracyte, VolitionRx, Nuvasive
This article was originally published in The Gray Sheet
Executive Summary
EnteroMedics founder and CEO to retire, Direct Flow Medical appoints VP, regulatory and clinical affairs, Veracyte names chief medical officer, and more personnel updates from around the industry.
You may also be interested in...
Direct Flow Taps Lemaitre To Lead Face Off With TAVR Giants
Direct Flow Medical hopes it May 7 appointment of Daniel Lemaitre as CEO will elevate its competitive game against larger players in the transcatheter aortic valve replacement market.
FDA Weighs Patients' Risk Tolerance in Approving Obesity Device
The agency approved EnteroMedics’ Maestro neuromodulator to treat obesity despite the device not meeting endpoints in its pivotal trial. The agency relied in part on a survey that found obese patients willing to take more risks in exchange for weight loss.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.